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1. Introduction 
Almost all Panax spp. (family Araliaceae) have been used in folk medicine. The most famous 
variety is P. ginseng, which was recorded in Chinese Materia Medica 2000 years ago. It is 
used to enhance stamina and capacity to cope with fatigue and physical stress, and in tonics 
against cancers, disturbances of the central nervous system (memory, learning, and 
behavior), hypothermia, carbohydrate and lipid metabolism, immune function, the 
cardiovascular system and radioprotection. Meanwhile, P. notoginseng, cultivated extensively 
in Kumming province in China, is also an important crude drug used as an astringent and 
tonic. P. japonicus grows mainly in Japan and China and is used as a stomachic and a hair-
growth tonic in Japan. In ginseng markets worldwide, P. quinquefolius usually commands a 
much higher price than P. ginseng. Since the roots of these ginseng products are similar in 
appearance and many commercial ginseng products are in the form of a powder or 
shredded slices, identification of the origins of ginseng products is not an easy task. 
Authentication of the sources of ginseng and ginseng products based on scientifically 
profiling has aroused much interest. 
Ginsenosides (ginseng saponins) are known to be bioactive components of ginseng. 
According to the difference in aglycon in these saponins, ginsenosides are classified into 
three types: the 20(S)-protopanaxadiol type [e.g., ginsenosides Rb1 (G-Rb1), -Rc (G-Rc), -Rb2 
(G-Rb2), -Rd (G-Rd); malonylginsenosides Rb1 (MG-Rb1), -Rb2 (MG-Rb2) and -Rc (MG-Rc)], 
the 20(S)-protopanaxatriol type [e.g., ginsenosides Rg1 (G-Rg1), -Rf (G-Rf), and -Re (G-Re)], 
and the oleanolic acid type [e.g., ginsenoside Ro (G-Ro)] (see Figure 1). Ginsenosides have 
been shown to affect various biological processes: e.g., tumor metastasis and anti-diabetes 
effects (Wu et al., 1992; Newman et al., 1992), the central nervous system (Kim et al., 1990; 
Kim et al.,1996; Tokuyama et al., 1996;), and retardation of the aging process (Metori et al., 
1997). It is well known that the content of ginsenosides varies in ginseng root or root extract 
depends on the method of extraction, subsequent treatment, or even the season of collection 
(Kim et al., 1981); therefore, standardization of quality is essential.  
Many analytical approaches have been used to identify ginsenosides in ginseng extract 
(Sticher and Soldati, 1979; Soldati and Sticher, 1980; Tani et al., 1981; Kitagawa et al., 1987; 
Yamaguchi et al., 1988; Samukawa et al., 1995; Wang et al., 1999; Chan et al., 2000; Li et al., 
2000). We have prepared monoclonal antibodies (MAbs) against major active compounds of 
P. ginseng, G-Rb1 (Tanaka et al., 1999) and G-Rg1 (Fukuda et al., 2000a), and established an  
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ELISA and an immunoaffinity concentration for ginsenosides (Fukuda et al., 1999; Fukuda et 
al., 2000b; Fukuda et al., 2001); however, no formation of MAb against the crude drug of P. 
ginseng has been reported, although immunological approaches for analyses of P. ginseng 
using a polyclonal antibody against P. ginseng have been investigated (Kitagawa et al., 1996). 
The present study describes the establishment of two MAbs against P. ginseng protein 
component, and the application of an ELISA for the qualitative analysis and classification of 
Panax spp. using the anti-P. ginseng MAbs.  
Previously, we used RAPD analysis for the homogeneity of regenerated Panax plants in 
vitro (Shoyama et al., 1995); however, we have not yet succeeded in distinguishing 
individual Panax spp. using their crude drugs. Therefore, we planned to perform a 
combination of RAPD and new double staining for ginsenosides by Eastern blotting using 
anti-G-Rb1, -Rg1 MAbs and to standardize the quality of ginseng. 
 
 
Fig. 1. Structures of ginsenosides 
2. Experimental 
2.1 Instrumentation 
Microtiter plates (Maxisorp) were purchased from Nalge Nunc (NY). The microplate reader 
was Model 450 (Bio-Rad Laboratories, CA). The PCR thermal cycler was a 1605 Air Thermo-
Cycler (Idaho Technology, UT). 
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2.2 Chemicals and immunochemicals 
Five kinds of commercial ginseng roots and other crude drugs were obtained from Nakai 
Koshindo (Kobe, Japan). Standards of ginsenosides were purchased from Wako Pure 
Chemical Ind., Ltd. (Osaka, Japan). Bovine serum albumin (BSA) and human serum albumin 
(HSA) were provided by Pierce (Rockford, IL). Polyvinylidene difluoride (PVDF) membranes 
were purchased from Millipore Corporation (Bedford, MA). A glass microfiber filter sheet 
(GF/A) was purchased from Whatman International Ltd. (Maidstone, UK). Peroxidase 
(POD)-labeled goat IgG fraction to mouse IgG was provided by ICN Pharmaceuticals Inc. 
(Aurora, OH). All other chemicals were standard commercial products of analytical grade.  
2.3 Immunization and hybridization  
Powdered white ginseng (P. ginseng) was suspended in phosphate-buffered saline (PBS), 
and extracted under sonication for 2 min. The white ginseng water-soluble fraction (WSF) 
obtained was immediately used as the immunogen. Mice were immunized by a protocol 
modified from Kitagawa (Kitagawa et al., 1996). First, BALB/c male mice were injected 
intraperitoneally with an initial injection of 500 μg WSF in PBS emulsified with an equal 
volume of Freund's complete adjuvant (Difco Laboratories, MI). Two boosts of 500 μg WSF 
in Freund’s incomplete adjuvant (Difco Laboratories, MI) were performed intraperitoneally 
at intervals of 2 weeks. The final immunization (1 mg) was injected as a PBS solution. On the 
third day after the final immunization, splenocytes were isolated and fused with a 
hypoxanthine-thymidine-aminopterin (HAT)-sensitive mouse myeloma cell line, P3-X63-
Ag8-U1, by the polyethylene glycol (PEG) method (Galfre and Milstein, 1981). Hybridoma-
producing MAb reactive to P. ginseng WSF were selected in enriched RPMI 1640-Dulbecco’s-
Ham’s F12 (eRDF; Kyokuto Pharmaceutical Industrial Co., Ltd., Tokyo, Japan) medium 
containing HAT, and cloned twice by the limited dilution method (Goding, 1980).  
Another hybridoma-producing MAb reactive to P. ginseng was prepared using red ginseng 
(P. ginseng) WSF as an immunogen by the above procedure. 
2.4 ELISA using MAbs against ginseng 
Dried samples (2.0 mg) of various ginseng and other crude drugs were powdered, 
suspended in 50 mM carbonate buffer at pH 9.6 (1.0 ml) under sonication for 10 min. The 
suspensions of ginseng WSF were diluted with 50 mM carbonate buffer at pH 9.6 and then 
assayed using ELISA.  
Reactivities of MAbs to various kinds of ginseng WSFs were determined by ELISA. The 
wells of a 96 well-immunoplate were coated with a suspension of 100 μl/well of various 
concentrations of ginseng WSF for 1 hr. The plate was washed three times with PBS 
containing 0.05% Tween 20 (TPBS), and then treated with 300 μl PBS containing 5% skim 
milk (SPBS) for 1 hr to reduce non-specific adsorption. The plate was again washed three 
times with TPBS and reacted with 100 μl test MAb for 1 hr. Again, the plate was washed 
three times with TPBS, and then incubated with 100 μl of 1,000 times dilution of POD-
labeled goat IgG fraction to mouse IgG for l hr. After washing a further three times with 
TPBS, 100 μl substrate solution [0.1 M citrate buffer (pH 4) containing 0.003% H2O2 and 0.3 
mg/ml of 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS)] 
was added to each well and incubated for 20 min. Absorbance was measured by a 
microplate reader at 405 nm. All reactions were carried out at 37 °C.  
The cross-reactivities (CR %) of various ginseng and other crude drugs were determined as 
follows: 
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where A is the absorbance of the test crude drug, APG is the absorbance of white ginseng, 
and Ao is the absorbance of the blank.  
2.5 Western blot analyses of P. ginseng WSFs 
Western blot analysis was carried out according to a reported method (essentially the 
method of Towbin) (Towbin et al., 1979). Reduced protein WSFs contained in suspensions of 
various ginseng (20 μg) in electrophoresis sample buffer were separated by SDS-
polyacrylamide electrophoresis (SDS-PAGE) (Laemmli, 1970) on 10% polyacrylamide gel, 
and electroblotted onto a PVDF membrane (Immobilon-P), which was then incubated with 
MAb to P. ginseng for 3 hr. The membrane was then incubated with 1,000 times dilution of 
POD-labeled goat IgG fraction to mouse IgG in PBS containing 0.2% gelatin (GPBS) for 1 hr. 
The POD-labeled secondary antibody bound to the membrane was then developed to blue 
bands with a substrate solution (4-chloro-1-naphthol soln.). 
2.6 Competitive ELISA using anti-G-Rb1, -Rg1 MAbs 
Dried samples (50 mg) of various ginseng were powdered and extracted with MeOH (5.0 
ml) under sonication five times. The combined extract was filtered and then evaporated to 
dryness. To eliminate the malonyl group from malonylated ginsenosides, the extracts were 
treated with 0.1% KOH in MeOH at room temperature for 1 hr. The combined extracts were 
diluted with 20% methanol suitable for competitive ELISA.  
G-Rb1-HSA (100 μl, 1 μg/ ml) dissolved in 50 mM carbonate buffer (pH 9.6) was adsorbed 
to the wells of a 96 well-immunoplate, and then treated with 300 μl SPBS for 1 hr to reduce 
non-specific adsorption. Fifty microliters of various concentrations of G-Rb1 or samples 
dissolved with 20% methanol were incubated with 50 μl MAb solution (83 μg/ml) for 1 hr. 
The plate was washed three times with PBS containing TPBS, and then incubated with 100 
μl of 1,000 times dilution of POD-labeled goat IgG fraction to mouse IgG for 1 hr. After 
washing the plate three times with TPBS, 100 μl substrate solution (ABTS soln.) was added 
to each well and incubated for 15 min. The absorbance was measured by a microplate reader 
at 405 nm. Quantitative analysis of G-Rg1 was performed by a similar competitive ELISA 
procedure as above. 
2.7 Double-stained Eastern blotting 
Ginsenosides and the extract of various ginseng were applied to TLC plates and developed 
with n-BuOH-EtOAc-H2O (15:1:4). One developed TLC plate was dried and sprayed with 
H2SO4. Another TLC plate was dried and then sprayed with blotting solution mixture of 
isopropanol-methanol-H2O (1:4:16, by volume). It was placed on a stainless steel plate and 
then covered with a PVDF membrane sheet. After covering with a glass microfiber filter 
sheet, it was pressed evenly for 50 s with a 120°C hot plate as previously described with 
modification (Fukuda et al., 2000b). The PVDF membrane was separated from the plate and 
dried. The blotted PVDF membrane was dipped in water containing NaIO4 (10 mg/ml) 
under stirring at room temperature for 1 hr. After washing with water, 50 mM carbonate 
buffer solution containing BSA was added and stirred for 3 hr. The PVDF membrane was 
washed with TPBS for 5 min twice and then washed with water. The PVDF membrane was 
immersed in anti-G-Rb1 MAb and stirred at room temperature for 1 hr. After washing the 
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PVDF membrane twice with TPBS and water, 1,000 times dilution of POD-labeled goat IgG 
fraction to mouse IgG in GPBS was added and stirred at room temperature for 1 hr. The 
POD-labeled secondary antibody bound to the membrane was then developed to blue 
bands with a substrate solution (4-chloro-1-naphthol soln.). 
In the experiment of the immunocytolocalization of G-Rb1, a sliced fresh P. ginseng root was 
placed on the PVDF membrane and they were pressed together evenly for 6 hr. The blotted 
PVDF membrane was stained using the same procedure as described for the Eastern 
blotting method.  
For staining with anti-G-Rg1 MAb, the blotted PVDF membrane was treated in the same 
way as anti-G-Rb1 MAb except that it was exposed to 2 mg of 3-amino-9-ethylcarbazole  
in 10 ml of 50 mM acetate buffer (pH 5.0) containing 0.03% H2O2 and 5%  
N,N-dimethylformamide.  
2.8 RAPD analysis  
DNA for RAPD analysis was extracted from the crude drug powder (100 mg) by the method 
of Murray and Thompson (1980) with some modification (Nakai et al., 1996). The obtained 
crude DNA was further purified by the Geneclean II kit (Bio 101, Illkirch, France) as follows: 
to the DNA solution, 6 M NaI at three times the volume of the DNA solution, plus Glass 
milk (5 μl) were added and mixed using a vortex mixer. The mixture was incubated at 0 °C 
for 10 min, with mixing every 1 min. After 10 min incubation, the mixture was centrifuged 
at 6,000 rpm at 2 °C for 30 s. The supernatant was removed and then washed with New 
Wash 3 times. Finally, the DNA fraction was centrifuged at 14,000 rpm at 2 °C for 30 s. The 
supernatant was removed. After the addition of sterile pure water (50 μl), the DNA solution 
was incubated at 55 °C for 5 min. The mixture was again centrifuged at 15,000 rpm at room 
temperature for 20 min. A 45 μl supernatant sample was recovered and the DNA 
concentration was determined using a U-3210 Spectrophotometer (Hitachi, Tokyo, Japan). 
Amplifications were carried out in 10 μl reaction volumes composed of 1.5 ng/μl plant 
DNA, 50 mM Tris/HCl (pH 8.5), 5 mM MgCl2, 500 μg/ml BSA, 2.0 % Ficol, 4 mM tartrazine, 
10 μM EDTA, and 0.04 units/μl Tth DNA polymerase (Toyobo, Osaka, Japan) (Nei and Li, 
1979). 
The Air Thermo-Cycler was programmed for 60 s at 94 °C, followed by 60 cycles of 10 s at 
94 °C, 30 s at 36 °C, and 60 s at 72 °C, followed by 120 s at 72 °C for amplification. 
Amplification products were separated in 1% agarose gels in 0.5 Tris/borate/EDTA (TBE) 
buffer. Gels containing ethidium bromide (5 μl/100 ml) were developed at 120 V for 3 hr. 
Gels were detected and photographed by a DNA transilluminator Model NTM-20 (UVP 
Inc., Upland, CA) at 302 nm. The sizes of the amplification products were estimated using a 
100 bp (100 bp-2.0 kb) ladder (Amersham Pharmacia Biotech, Buckinghamshire, UK). The 
random primers consisted of ten base sequences from a kit purchased from QIAGEN 
Operon Technologies Inc. (Chatsworth, CA). The OPB and OPO series, having ten base 
sequences that had been synthesized previously (Nakai et al., 1996), were as follows:  
OPB-01 (5’-GTTTCGCTCC-3’), OPB-02 (5’-TGATCCCTGG-3’),  
OPB-03 (5’-CATCCCCCTG-3’), OPB-04 (5’-GGACTGGAGT-3’),  
OPB-05 (5’-TGCGCCCTTC-3’), OPB-06 (5’-TGCTCTGCCC-3’),  
OPB-07 (5’-GGTGACGCAG-3’), OPB-08 (5’-GTCCACACGG-3’),  
OPB-09 (5’-TGGGGGACTC-3’), OPB-12 (5’-CCTTGACGCA-3’),  
OPB-13 (5’-TTCCCCCGCT-3’), OPB-14 (5’-TCCGCTCTGG-3’),  
OPB-18 (5’-CCACAGCAGT-3’), OPB-19 (5’-ACCCCCGAAG-3’),  
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OPO-03 (5’-CTGTTGCTAC-3’), OPO-04 (5’-AAGTCCGCTC-3’),  
OPO-08 (5’-CCTCCAGTGT-3’), OPO-09 (5’-TCCCACGCAA-3’),  
OPO-10 (5’-TCAGAGCGCC-3’), OPO-12 (5’-CAGTGCTGTG-3’),  
OPC-18 (5’-CTCGCTATCC-3’) 
Genetically similar (F) values were determined by Nei and Li’s method (1979). 
3. Results and discussion 
3.1 ELISA using MAbs against ginseng 
This paper demonstrated ELISA for Panax spp. using two kinds of MAbs against P. ginseng 
protein components. Hyperimmunized BALB/c mice with ginseng WSF yielded splenocytes 
which were fused with P3-X63-Ag8-U1 myeloma cells by a routine procedure established in 
our laboratory (Sakata et al., 1994). After additional testing with ELISA employing various 
ginseng, two hybridoma-producing MAbs were cloned and expanded. MAb 3H4 was 
produced from white ginseng WSF as an immunogen, whereas MAb 5H8 was produced 
from red ginseng WSF as an immunogen. Two MAbs reactive to P. ginseng were classified 
into IgG1 with k light chains. 
MAbs that bound to the ginseng protein components on the surface of the wells were then 
reacted with POD-labeled goat anti-mouse IgG as the secondary antibody in ELISA using 
MAbs 3H4 and 5H8. First, the reactivity of IgG-type MAbs 3H4 and 5H8 to various 
concentrations of P. ginseng protein components was tested by varying antibody 
concentrations and by performing a dilution curve. In general, the color development 
intensity was regulated at around 1 for a highly reliable ELISA result. Optical antibody 
concentrations (MAb 3H4; 0.01 μg/ml, MAb 5H8; 5 μg/ml) of absorbance of approximately 
1 were selected for the determination of cross-reactivities against crude drugs by ELISA.  
 
 
Fig. 2. Typical dose–response curves for five types of ginsengs measured by ELISA using 
MAbs 3H4 and 5H8. In order to examine the specificity of the ELISA, MAbs reactive to P. 
ginseng (MAb 3H4, 0.01 μg/mL; MAb 5H8, 5 μg/mL) were added to each well of a 96-well 
immunoplate coated with various concentrations of powdered drug material from white 
ginseng (○), red ginseng (●), Panax notoginseng (□), P. quinquefolius (■) and P. japonicus (∆). 
Values plotted are means (n = 3) 
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3.2 Cross-reactivity of MAbs 3H4 and 5H8 against various crude drugs  
Figure 2 shows typical dose response curves of five kinds of ginseng measured by ELISA 
using MAbs 3H4 and 5H8. ELISA using MAb 3H4 was not specific to P. ginseng and showed 
cross-reactivity with P. notoginseng and P. quinquefolius, but did not react with other crude 
drugs. This wide cross-reactivity is the major advantage of the antibody reagent used in this 
ELISA. Although both MAbs 3H4 and 5H8 cross-reacted with the P. ginseng protein 
components, the cross-reactivity against other Panax spp. varied, as shown in Table 1. The 
most important property of this MAb 3H4 is its ability to distinguish ginseng produced 
from P. ginseng by processing, since 3H4 did not react with red ginseng. MAb 5H8 has weak 
cross-reactivity with P. notoginseng, P. quinquefolius and P. japonicas; however, since MAb 
5H8 cross-reacted with Scopoliae rhizoma, other assay methods such as our ELISA using 
anti-G-Rb1 and -Rg1 MAbs might be needed.  
 
Cross-reactivity (%)a 
Crude drug 
3H4 5H8 
White ginseng (Panax ginseng)  
Red ginseng (P. ginseng)  
San-chi ginseng (P. notoginseng)  
American ginseng (P. quinquefolius)  
Japanese ginseng (P. japonicus) 
Scopoliae Rhizoma  
Gardeniae Fructus  
Glycyrrhizae Radix  
Uvae Ursi Folium  
Phellodendri Cortex  
Sennae Folium  
Paeoniae Radix  
Bupleuri Radix  
Senegae Radix  
Rhei Rhizoma  
Aurantii Pericarpium  
Coptidis Rhizoma  
Cinnamomi Cortex  
Scutellariae Radix  
100 
<1 
53.4 
43.1 
1.4 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
100 
204 
4.4 
2.4 
3.2 
20.2 
4.5 
3.0 
2.7 
2.7 
2.1 
1.5 
1.3 
1.3 
1.2 
<1 
<1 
<1 
<1 
aValues are means ± standard deviation (n = 3). 
Table 1. Cross-reactivity (CR%) of MAbs against various ginseng and other crude drugs 
assayed using the ELISA method 
3.3 Detection of protein specific to MAbs against ginseng 
Blot analysis demonstrated that MAb 3H4 reacted with two major bands, Mr 24 kDa and 29 
kDa, contained in 3 kinds of ginseng, as indicated in Figure 3. This observation suggests that 
the epitope is common to the two proteins. Judging from these results, MAb 3H4 might 
recognize common ginseng protein components contained in all Panax spp. On the other 
hand, MAb 5H8 selectively reacted with a broad band which roughly corresponds with 
bands at approximately Mr 24-29 kDa in P. ginseng, shown in Figure 3. This does not 
correspond to the result of the ELISA where MAb 5H8 reacted with P. ginseng and red 
www.intechopen.com
 
Quality Control of Herbal Medicines and Related Areas 
 
276 
ginseng, suggesting that the immunogenic proteins were probably denatured during the 
manufacturing process and might not have been separated by SDS-PAGE. 
 
 
Fig. 3. SDS-PAGE and western blotting analyses of various ginsengs using MAbs 3H4 and 
5H8. Samples were resolved by electrophoresis on a 10% acrylamide gel. Proteins were 
stained with Coomassie Brilliant Blue. Proteins separated by SDS-PAGE were transferred 
onto the PVDF membranes and incubated with MAbs 3H4 and 5H8. The bound MAb was 
reacted with PODlabelled secondary antibody, followed by reaction with substrate in order 
to develop blue protein bands. Lane 1, white ginseng (Panax ginseng; lane 2, red ginseng  
(P. ginseng), lane 3, sanchi-ginseng (P. notoginseng); lane 4, American ginseng (P. quinquefolius); 
lane 5, Japanese ginseng (P. japonicus). Molecular weights are as indicated by arrows 
We established two MAbs that reacted predominantly with P. ginseng protein components 
to develop new immunological methods for analysis of Panax spp., resulting in two ELISAs 
using two MAbs. MAb 3H4, showing specific reactivity against ginseng, is predicted to be a 
probe for immunochemical discrimination between Panax spp. and other crude drugs. In 
addition, ELISA using MAb 5H8 can distinguish P. ginseng and red ginseng from other 
Panax spp. It became evident that the discrimination between white ginseng and red 
ginseng was could be performed by Western blotting. This assay is also technically easy to 
perform and allows small amounts of sample to be analyzed, as demonstrated by this study. 
The ELISA developed in this paper can be utilized for a homogeneity assay of Panax spp., 
therefore making it possible to study in the phytochemical field. 
3.4 G-Rb1 and -Rg1 concentrations in Panax spp. measured by ELISA 
G-Rb1 and -Rg1 were quantitatively determined by the competitive ELISA that we 
developed previously (Tanaka et al., 1999; Fukuda et al., 2000a). Kitagawa et al. isolated 
malonyl ginsenosides from white ginseng, finding that non-processed ginseng contents are 
higher than in processed ginseng (Kitagawa et al., 1983). It is thought that MG-Rb1 
influences ELISA since it is suggested that MG-Rb1 has similar cross-reactivity with G-Rb1. 
Therefore, G-Rb1 concentrations in various Panax spp. were measured after MG-Rb1 had 
been converted into G-Rb1 by mild alkaline conditions. The concentrations of G-Rb1 and -
Rg1 are shown in Table 2 and vary according to species. Fibrous ginseng, which is made 
from the actively growing part of P. ginseng, showed the highest G-Rb1 concentration, 64.4 ± 
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3.6 mg/g dry wt. P. notoginseng and P. quinquefolius also showed high concentrations, 47.1 ± 
3.3 and 48.5 ± 1.8 mg/g dry wt., respectively; however, the G-Rb1 concentration in P. 
japonicus analyzed by ELISA must be inaccurate since a very high S.D. of the G-Rb1 
concentration in P. japonicus is shown in Table 2. In the present study, P. notoginseng showed 
the highest G-Rg1 concentration, 22.9 ± 3.2 mg/g dry wt. Also fibrous ginseng showed a 
high concentration, 4.98 ± 0.04 mg/g dry wt. The concentrations determined by ELISA 
agreed well with those determined by HPLC (Kitagawa et al., 1987). ELISA was more 
sensitive than TLC (Tani et al., 1981) or HPLC (Sticher and Sticher, 1979; Soldati and Sticher, 
1980). Moreover, Yamaguchi et al. (1988) and Samukawa et al. (1995) reported the 
comparative concentrations of ginsenosides in various commercial ginseng radices analyzed 
by HPLC. The results obtained in this investigation indicate that the determination of 
ginsenoside concentrations could be carried out semi-quantitatively by ELISA, which might 
become a promising tool for the standardization of ginseng samples. 
 
Sample 
G-Rb1 content 
(mg/g dry weight) a 
G-Rg1 content 
(mg/g dry weight)a 
Ginseng (Panax ginseng)  
Red Ginseng (P. ginseng)  
Fibrous Ginseng (P. ginseng)  
San-chi Ginseng (P. notoginseng)  
American Ginseng (P. quinquefolius)  
Janpanese Ginseng (P. japonicus)  
5.49 ± 0.75 
3.57 ± 0.62 
64.4 ± 3.6 
47.1 ± 3.3 
48.5 ± 1.8 
1.37 ± 0.34 
2.28 ± 0.02 
1.34 ± 0.08 
4.98 ± 0.04 
22.9 ± 3.2 
3.15 ± 0.23 
0.12 ± 0.01 
a Values are means ± standard deviation (n = 3). 
Table 2. Quantitative determination of ginsenosides Rb1 and Rg1 in various ginsengs using 
the ELISA method 
3.5 Double-stained Eastern blotting of ginsenosides using anti-G-Rb1 and anti-G-Rg1 
MAbs  
Direct detection of small molecular compounds on a TLC plate by immunostaining is 
impossible because they are easily washed out by buffer solution without fixing. We 
therefore designed a system in which ginsenosides were blotted onto a PVDF membrane 
from the developed TLC plate for immunostaining. After ginsenosides had been transferred 
to the PVDF membrane, it was treated with NaIO4 solution, followed by the addition of 
BSA. This reaction enhanced the fixation of ginsenosides via ginsenoside-BSA conjugate on 
the PVDF membrane. Figure 4-B indicates the Eastern blotting patterns of ginsenosides 
using anti-G-Rb1 MAb in three kinds of Panax spp., P. ginseng, P. notoginseng and P. 
quinquefolius.  
Figure 4-C shows the Eastern blotting of double staining using anti-G-Rb1 and -Rg1 MAbs 
for ginsenoside standards. When the mixture of anti-G-Rg1 and -Rb1 MAbs and the pair of 
substrates were tested for staining of ginsenosides, all ginsenosides, G-Rg1, -Re, -Rd, -Rc 
and -Rb1, stained blue (data not shown), although purple staining for G-Rg1 was expected 
because 3-amino-9-ethylcarbazole was used as the substrate. It can therefore be suggested 
that the sensitivities of the substrate between 3-amino-9-ethylcarbazole and 4-chloro-1-
naphtol might be different, so we performed successive staining of the PVDF membrane 
using anti-G-Rg1 and then anti-G-Rb1. Finally, we succeeded in the double staining of 
ginsenosides, indicating that G-Rg1 and -Re were stained purple and the other blue, 
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separately, as indicated in Fig. 4-C. From these results, both antibodies could distinguish 
individual aglycons, 20(S)-protopanaxatriol and 20(S)-protopanaxadiol. For this application, 
crude extracts of three Panax spp. were analyzed by the newly developed double-staining 
system. Major ginsenosides could be determined clearly by this double-staining method. G-
Rb1, -Rc and -Rd possessing 20(S)-protopanaxadiol as an aglycon stained as blue bands, and 
G-Re and -Rg1 as purple, depending on the substrate (4-chloro-1-naphtol). Figure 4-D shows 
the double staining of Eastern blotting for three Panax spp. When compared to the single 
staining of Eastern blotting by anti-G-Rb1 MAb (Fig. 4-B), it became evident that the quality 
of Panax spp. regarding ginsenosides varied. P. notoginseng contained a higher amount of G-
Rg1, but G-Rc disappeared (Fig. 4-D, lane 4). A higher amount of G-Re and trace amounts of 
G-Rd and -Rg1 were observed in P. quinquefolius, as indicated in Fig. 4-D, lane 5. Three 
bands stained red by anti-G-Rg1 MAb were found, as indicated by arrows, although they 
could not be detected by staining with anti-G-Rb1 MAb. It is suggested that these bands 
might be related to G-Rg1 and G-Re having 20(S)-protopanaxatriol as an aglycon in the 
molecule. A survey of previous papers (Shoji, 1990) suggested that the three unknown bands 
could be determined as G-Rh1, G-Rf and 20-gluco G-Rf, which are mono-, di- and triglycosides 
of 20(S)-protopanaxatriol, respectively, depending upon individual Rf values. This finding 
suggests that the structures of aglycon can be recognized from the band color, and the Rf 
value is reflected by the sugar number. Using this result, we determined two bands under 
G-Rb1 as MG-Rb1 (Kitagawa et al., 1983) and 20-O-gentiobiosyl-chikusetsusaponin III (Shoji, 
1990), which has five sugars in a molecule of P. ginseng, in good agreement with the Rf value 
previously reported (Kitagawa et al., 1983; Shoji, 1990). Finally, these two compounds were 
identified by comparing with authentic samples (data not shown).  
 
 
Fig. 4. Staining of various Panax samples. (A) Sulphuric acid staining; (B) eastern blotting 
using anti-G-Rb1 MAb; and (D) double-stain eastern blotting using anti-G-Rb1 and –Rg1 
MAbs. Lanes 1–6 show white ginseng, red ginseng, fibrous ginseng, P. notoginseng, P. 
quinquefolius and P. japonicus (60 μg), respectively. (C) Double-stain eastern blotting of 
ginsenoside standards using anti-G-Rb1 and -G-Rg1 MAbs. Lanes 1–5 show G-Rb1, –Rc,  
–Rd, –Re and –Rg1 (3 μg), respectively 
Figure 5 illustrates the immunocytolocalization of G-Rb1 in fresh P. ginseng roots. The 
phloem contained a higher concentration of G-Rb1 than the xylem. We conducted a 
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controlled study with a slice of fresh Glycyrrhiza root using the same procedure to evaluate 
the specific detection of ginsenosides in the P. ginseng root with this system. In consequence, 
the Glycyrrhiza root, although it contained saponins structurally related to G-Rb1, was not 
immunostained by the Eastern blotting method using anti-G-Rb1 MAb 9G7, indicating the 
high specificity for Panax spp. of this method (data not shown). 
 
 
Fig. 5. Immunocytolocalisation of G-Rb1 in Panax ginseng root using anti-G-Rb1 MAb 
3.6 RAPD analysis 
The total DNA extracted from the crude drugs of Panax spp. was analyzed by RAPD using 
21 random primers, resulting in 113 total bands. Figure 6 shows a representative amplified 
band pattern identified by primers. 
 
 
Fig. 6. Detection of polymorphic bands among Panax species using primer (A) OPO-08 (5′-
CCTCCAGTGT-3′) and (B) OPB-05 (5′-TGCGCCCTTC-3′). Lanes 1–4 show P. notoginseng, P. 
japonicus, P. ginseng and P. quinquefolius, respectively 
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The genetic distance matrix between individual species was calculated according to Nei and 
Li’s method (1979). The degree of similarity among their fingerprints confirmed that P. 
ginseng is more closely related to P. quinquefolius than to P. japonicus. This result corresponds 
to the conclusions based on morphological taxonomic studies (Hara, 1970). It is suggested 
that RAPD analysis may be a useful method for determining the quality and homogeneity of 
Panax spp. as previously reported for regenerated plants of Panax spp. in vitro (Shoyama et 
al., 1988). 
4. Conclusion 
The combination of RAPD and the developed double-stained Eastern blotting method can 
authenticate P. notoginseng and P. japonicus. Double-stained Eastern blotting indicated that 
P. notoginseng roots did not contain G-Rc, although the TLC profile was unclear. These 
results therefore suggest that a combination system of ELISA using MAbs, double-stained 
Eastern blotting and RAPD could identify four Panax spp. Moreover, a newly established 
immunocytolocalization method clearly shows not only the distribution of ginsenosides in 
ginseng roots, but also differentiates ginseng from other crude drugs. 
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